Esophageal candidiasis-an adverse effect of inhaled corticosteroids therapy

Journal of Asthma

Volumn 46, Issue 4, 2009, Pages 399-401

  Aun, Marcelo Vivolo ^a   Ribeiro, Marisa Rosimeire ^a   Costa Garcia, Claudia Leite ^a   Agondi, Rosana Camara ^a   Kalil, Jorge ^a   Giavina Bianchi, Pedro ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Asthma; Budesonide; Drug adverse reaction; Esophageal candidiasis; Inhaled corticosteroid

Indexed keywords

BUDESONIDE; FORMOTEROL; CORTICOSTEROID; ETHANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; ASTHMA; CASE REPORT; CORTICOSTEROID THERAPY; DEVICE; DIABETES MELLITUS; DRY POWDER; ESOPHAGUS CANDIDIASIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; JAPAN; MALE; MORTALITY; NEOPLASM; PREVALENCE; RARE DISEASE; SYMPTOMATOLOGY; CANDIDIASIS; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; EPIDEMIOLOGY; ESOPHAGUS DISEASE; FOLLOW UP; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; RISK ASSESSMENT;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; ASTHMA; BUDESONIDE; CANDIDIASIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGEAL DISEASES; ETHANOLAMINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; RISK ASSESSMENT; SAMPLING STUDIES;

EID: 67649816357     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900902777783     Document Type: Article

References (17)

1. Bateman ED, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31:143-178.
2. Toogood JH. Complications of topical steroid therapy for asthma. Rev Respir Dis 1990; 141:S89-96.
3. Simon MR, Houser WL, Smith KA, Long PM. Esophageal candidiasis as a complication of inhaled corticosteroids. Ann Allergy Asthma Immunol 1997; 79: 333-338.
4. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 3; 2007. National Institutes of Health (section on ICS local adverse effects).
5. Kanda N, Yasuba H, Takahashi T, Mizuhara Y, Yamazaki S, Imada Y, Izumi Y, Kobayashi Y, Yamashita K, Kita H, Tamada T, Chiba T. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol 2003; 98(10):2146-2148.
6. Shuto H, Nagata M, Terashi Y, Yamaguchi M, Takizawa T, Shuto C, Watanabe K, Tosaka K, Okano M, Noguchi H. Esophageal candidiasis as complication of inhaled steroid therapy. Arerugi 2003; 52(11):1053-1064.
7. Kobayashi Y, Yasuba H, Kudou M, Hamada K, Kita H. Esophageal candidi-asis as a side effect of inhaled fluticasone propionate dry powder: recovery by switching over to hydrofluoroalkane-134a beclomethasone dipropionate (HFA-BDP). Int J Clin Pharmacol Ther 2006; 44(5):193-197.
8. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003; 90(6):646-651.
9. Stein MR, Shay SS, Jacobson K. Monilial asophagitis in asthmatic patients treated with beclomethasone. J Allergy Clin Immunol 1979; 63:172.
10. Hemstreet MP, Reynolds DW, Meadows J Jr. Oesophagitis - a complication of inhaled steroid therapy. Clin Allergy 1980; 10:733-738.
11. Kesten S, Hyland RH, Pruzanski WR, Kortan PP. Esophageal candidiasis associated with beclomethasone dipropionate aerosol therapy. Drug Intell Clin Pharm 1988; 22(7-8):568-569.
12. Sievert W, Holmes P, King RW. Oesophageal candidosis in patients on high-dose inhaled steroids. Lancet 1992; 339(8808):1551-1552.
13. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson SA. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129(5):723-729.
14. Salzman GA, Pyszczynski DR. Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with aerochamber. J Allergy Clin Immunol 1988; 81(2):424-428.
15. Mullaoglu S, Turktas H, Kokturk N, Tuncer C, Kalkanci A, Kustimur S. Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. Allergy Asthma Proc 2007; 28(5):544-549.
16. Lipworth RJ. New perspectives on inhaled drug delivery and systemic bioactivity. Thorax 1995; 50:105-110.
17. Leach CL, Davidson PJ, Bredow TS, Boudreau RJ. Patient factors influencing the deposition of HFA-beclomethasone dipropionate metered dose inhaler. Eur Respir J 1998a; 12:66s.